Pathogenic variants in MT-ATP6: A United Kingdom–based mitochondrial disease cohort study
<p>Distinct clinical syndromes have been associated with pathogenic <em>MT‐ATP6</em> variants. In this cohort study, we identified 125 individuals (60 families) including 88 clinically affected individuals and 37 asymptomatic carriers. Thirty‐one individuals presented with Leigh sy...
| Principais autores: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Journal article |
| Idioma: | English |
| Publicado em: |
Wiley
2019
|
| _version_ | 1826279296442826752 |
|---|---|
| author | Ng, YS Martikainen, MH Gorman, GS Blain, A Bugiardini, E Bunting, A Schaefer, AM Alston, CL Blakely, EL Sharma, S Hughes, I Lim, A Degoede, C McEntagart, M Spinty, S Horrocks, I Roberts, M Woodward, CE Chinnery, PF Horvath, R Nesbitt, V Fratter, C Poulton, J Hanna, MG Pitceathly, RDS Taylor, RW Turnbull, DM McFarland, R |
| author_facet | Ng, YS Martikainen, MH Gorman, GS Blain, A Bugiardini, E Bunting, A Schaefer, AM Alston, CL Blakely, EL Sharma, S Hughes, I Lim, A Degoede, C McEntagart, M Spinty, S Horrocks, I Roberts, M Woodward, CE Chinnery, PF Horvath, R Nesbitt, V Fratter, C Poulton, J Hanna, MG Pitceathly, RDS Taylor, RW Turnbull, DM McFarland, R |
| author_sort | Ng, YS |
| collection | OXFORD |
| description | <p>Distinct clinical syndromes have been associated with pathogenic <em>MT‐ATP6</em> variants. In this cohort study, we identified 125 individuals (60 families) including 88 clinically affected individuals and 37 asymptomatic carriers. Thirty‐one individuals presented with Leigh syndrome and 7 with neuropathy ataxia retinitis pigmentosa. The remaining 50 patients presented with variable nonsyndromic features including ataxia, neuropathy, and learning disability. We confirmed maternal inheritance in 39 families and demonstrated that tissue segregation patterns and phenotypic threshold are variant dependent. Our findings suggest that <em>MT‐ATP6</em>–related mitochondrial DNA disease is best conceptualized as a mitochondrial disease spectrum disorder and should be routinely included in genetic ataxia and neuropathy gene panels.</p> |
| first_indexed | 2024-03-06T23:56:36Z |
| format | Journal article |
| id | oxford-uuid:746ec7b7-24fe-41d8-adf9-ab535744b1d1 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T23:56:36Z |
| publishDate | 2019 |
| publisher | Wiley |
| record_format | dspace |
| spelling | oxford-uuid:746ec7b7-24fe-41d8-adf9-ab535744b1d12022-03-26T20:02:51ZPathogenic variants in MT-ATP6: A United Kingdom–based mitochondrial disease cohort studyJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:746ec7b7-24fe-41d8-adf9-ab535744b1d1EnglishSymplectic Elements at OxfordWiley2019Ng, YSMartikainen, MHGorman, GSBlain, ABugiardini, EBunting, ASchaefer, AMAlston, CLBlakely, ELSharma, SHughes, ILim, ADegoede, CMcEntagart, MSpinty, SHorrocks, IRoberts, MWoodward, CEChinnery, PFHorvath, RNesbitt, VFratter, CPoulton, JHanna, MGPitceathly, RDSTaylor, RWTurnbull, DMMcFarland, R<p>Distinct clinical syndromes have been associated with pathogenic <em>MT‐ATP6</em> variants. In this cohort study, we identified 125 individuals (60 families) including 88 clinically affected individuals and 37 asymptomatic carriers. Thirty‐one individuals presented with Leigh syndrome and 7 with neuropathy ataxia retinitis pigmentosa. The remaining 50 patients presented with variable nonsyndromic features including ataxia, neuropathy, and learning disability. We confirmed maternal inheritance in 39 families and demonstrated that tissue segregation patterns and phenotypic threshold are variant dependent. Our findings suggest that <em>MT‐ATP6</em>–related mitochondrial DNA disease is best conceptualized as a mitochondrial disease spectrum disorder and should be routinely included in genetic ataxia and neuropathy gene panels.</p> |
| spellingShingle | Ng, YS Martikainen, MH Gorman, GS Blain, A Bugiardini, E Bunting, A Schaefer, AM Alston, CL Blakely, EL Sharma, S Hughes, I Lim, A Degoede, C McEntagart, M Spinty, S Horrocks, I Roberts, M Woodward, CE Chinnery, PF Horvath, R Nesbitt, V Fratter, C Poulton, J Hanna, MG Pitceathly, RDS Taylor, RW Turnbull, DM McFarland, R Pathogenic variants in MT-ATP6: A United Kingdom–based mitochondrial disease cohort study |
| title | Pathogenic variants in MT-ATP6: A United Kingdom–based mitochondrial disease cohort study |
| title_full | Pathogenic variants in MT-ATP6: A United Kingdom–based mitochondrial disease cohort study |
| title_fullStr | Pathogenic variants in MT-ATP6: A United Kingdom–based mitochondrial disease cohort study |
| title_full_unstemmed | Pathogenic variants in MT-ATP6: A United Kingdom–based mitochondrial disease cohort study |
| title_short | Pathogenic variants in MT-ATP6: A United Kingdom–based mitochondrial disease cohort study |
| title_sort | pathogenic variants in mt atp6 a united kingdom based mitochondrial disease cohort study |
| work_keys_str_mv | AT ngys pathogenicvariantsinmtatp6aunitedkingdombasedmitochondrialdiseasecohortstudy AT martikainenmh pathogenicvariantsinmtatp6aunitedkingdombasedmitochondrialdiseasecohortstudy AT gormangs pathogenicvariantsinmtatp6aunitedkingdombasedmitochondrialdiseasecohortstudy AT blaina pathogenicvariantsinmtatp6aunitedkingdombasedmitochondrialdiseasecohortstudy AT bugiardinie pathogenicvariantsinmtatp6aunitedkingdombasedmitochondrialdiseasecohortstudy AT buntinga pathogenicvariantsinmtatp6aunitedkingdombasedmitochondrialdiseasecohortstudy AT schaeferam pathogenicvariantsinmtatp6aunitedkingdombasedmitochondrialdiseasecohortstudy AT alstoncl pathogenicvariantsinmtatp6aunitedkingdombasedmitochondrialdiseasecohortstudy AT blakelyel pathogenicvariantsinmtatp6aunitedkingdombasedmitochondrialdiseasecohortstudy AT sharmas pathogenicvariantsinmtatp6aunitedkingdombasedmitochondrialdiseasecohortstudy AT hughesi pathogenicvariantsinmtatp6aunitedkingdombasedmitochondrialdiseasecohortstudy AT lima pathogenicvariantsinmtatp6aunitedkingdombasedmitochondrialdiseasecohortstudy AT degoedec pathogenicvariantsinmtatp6aunitedkingdombasedmitochondrialdiseasecohortstudy AT mcentagartm pathogenicvariantsinmtatp6aunitedkingdombasedmitochondrialdiseasecohortstudy AT spintys pathogenicvariantsinmtatp6aunitedkingdombasedmitochondrialdiseasecohortstudy AT horrocksi pathogenicvariantsinmtatp6aunitedkingdombasedmitochondrialdiseasecohortstudy AT robertsm pathogenicvariantsinmtatp6aunitedkingdombasedmitochondrialdiseasecohortstudy AT woodwardce pathogenicvariantsinmtatp6aunitedkingdombasedmitochondrialdiseasecohortstudy AT chinnerypf pathogenicvariantsinmtatp6aunitedkingdombasedmitochondrialdiseasecohortstudy AT horvathr pathogenicvariantsinmtatp6aunitedkingdombasedmitochondrialdiseasecohortstudy AT nesbittv pathogenicvariantsinmtatp6aunitedkingdombasedmitochondrialdiseasecohortstudy AT fratterc pathogenicvariantsinmtatp6aunitedkingdombasedmitochondrialdiseasecohortstudy AT poultonj pathogenicvariantsinmtatp6aunitedkingdombasedmitochondrialdiseasecohortstudy AT hannamg pathogenicvariantsinmtatp6aunitedkingdombasedmitochondrialdiseasecohortstudy AT pitceathlyrds pathogenicvariantsinmtatp6aunitedkingdombasedmitochondrialdiseasecohortstudy AT taylorrw pathogenicvariantsinmtatp6aunitedkingdombasedmitochondrialdiseasecohortstudy AT turnbulldm pathogenicvariantsinmtatp6aunitedkingdombasedmitochondrialdiseasecohortstudy AT mcfarlandr pathogenicvariantsinmtatp6aunitedkingdombasedmitochondrialdiseasecohortstudy |